The Peptide Gamble

Why GLP-1s, BPC-157, and SS-31 are everywhere despite of minimal human data - and how to think about your personal risk tolerance

One thing is clear: peptides are not going away.

I get the question constantly now.

“Do you have a peptide person in [insert city name]?”

Having one has become a status symbol, like knowing a guy who knows a guy.

I used to think Hims & Hers prescribing GLP-1s with essentially zero oversight was reckless. I still do. But now everyone’s entering the game - …